Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00230841
Other study ID # 0020010158
Secondary ID
Status Completed
Phase Phase 2
First received September 29, 2005
Last updated July 31, 2013
Start date September 2001
Est. completion date April 2004

Study information

Verified date July 2013
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

Croup affects 5% of children under 6 years of age, resulting in visits to hospital Emergency Departments, and in 1% of children, hospitalization. Traditionally, the first therapy offered is humidification which can liquify airway secretions and decrease airway swelling. This study will compare the effectivenesss of 40% and 100% humidity through a specially designed machine called a nebulizer, with the usual humidity set-up (blown into the patient's face from a hose).


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date April 2004
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 3 Months to 10 Years
Eligibility Inclusion Criteria:

- children aged 3 months - 10 years

- croup score greater than or equal to 2 after a 30 minute waiting period

Exclusion Criteria:

- Symptoms of croup requiring immediate intervention with nebulized epinephrine or intubation

- symptoms or signs of alternative causes of stridor

- inability of caregivers to understand or speak English and/or sign for informed consent

- history of chronic pulmonary disease except for asthma, or co-existent systemic disease

- previous history of intubation

- duration of present illness >1 week

- systemic or inhaled glucocorticoids in previous 48 hours

- epinephrine in previous 4 hours

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
nebulized humidity


Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
The Hospital for Sick Children The Physicians' Services Incorporated Foundation

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Scolnik D, Coates AL, Stephens D, Da Silva Z, Lavine E, Schuh S. Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments: a randomized controlled trial. JAMA. 2006 Mar 15;295(11):1274-80. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary changes in the croup score from baseline to 30 and 60 minutes
Secondary steroid or epinephrine treatment at 60 minutes
Secondary discharge rate at 60 minutes
Secondary change in pulse, respiratory rate, and oxygen saturation at 60 minutes
See also
  Status Clinical Trial Phase
Terminated NCT01748162 - Management of Recurrent Croup Phase 3
Terminated NCT00147849 - A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup N/A
Terminated NCT03705273 - Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup Phase 4
Completed NCT01042145 - Community Care for Croup (RCT) Phase 4
Completed NCT00368823 - A Trial of Point of Care Information in Ambulatory Pediatrics Phase 3
Completed NCT05668364 - Impact of Cold Air Exposure on Croup Symptoms N/A
Not yet recruiting NCT06272383 - Croup Dosing Study Phase 1
Completed NCT03392363 - Diagnosing Respiratory Disease in Children Using Cough Sounds 2
Recruiting NCT01664507 - The Effect and Safety of Low Dose Nebulized Epinephrine in Croup Phase 4
Completed NCT06156436 - A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
Not yet recruiting NCT04168554 - Telemedicine in the Generals Practitioners Office
Completed NCT02973282 - Diagnosing Respiratory Disease in Children Using Cough Sounds N/A
Terminated NCT00938353 - Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup Phase 3